Related Experiment Videos
[Biochemical modulation in cancer chemotherapy].
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|April 1, 1985
Summary
Methotrexate (MTX) alters intracellular nucleotide pools, enhancing chemotherapy efficacy. MTX combined with 5-FU or ara-C shows synergistic effects by modulating active metabolite levels and purine pathways.
Area of Science:
- Biochemistry
- Pharmacology
- Molecular Biology
Context:
- Understanding intracellular nucleic acid metabolism is crucial for developing targeted chemotherapy.
- Antimetabolites like Methotrexate (MTX) can be biochemically modulated for improved selectivity.
- L1210 mouse leukemic cells provide a model for studying drug effects on nucleotide pools.
Purpose:
- To analyze sequential changes in intracellular nucleotide pools of L1210 cells after MTX treatment.
- To investigate the biochemical mechanisms underlying the synergistic effects of MTX in combination chemotherapy with 5-Fluorouracil (5-FU) and Cytarabine (ara-C).
Summary:
- High-performance liquid chromatography revealed significant reductions in dTTP, dCTP, ATP, and GTP pools following MTX treatment.
- MTX pretreatment enhanced intracellular FUTP levels in MTX-5-FU combination therapy, potentially via PRPP level increase due to MTX-blocked purine de novo pathway.
- MTX enhanced ara-CTP production in MTX-ara-C combination therapy by reducing intracellular dCTP pools, activating deoxycytidine kinase.
Impact:
- Clarifying MTX's effects on intracellular nucleic acid metabolism can guide the development of novel, effective drug combinations, including thiopurines.
- Understanding biochemical modulation enhances the sophistication of combination chemotherapy strategies.
- Findings contribute to the rational design of more selective and effective cancer chemotherapies.